AJO, LP - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AJO, LP ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$2,000,000
+22.2%
43,723
+34.1%
0.02%
+40.0%
Q2 2020$1,637,000
+51.4%
32,615
+55.1%
0.02%
+50.0%
Q1 2020$1,081,000
-83.1%
21,029
-79.7%
0.01%
-73.7%
Q4 2019$6,391,000
+50.3%
103,454
+46.2%
0.04%
+52.0%
Q3 2019$4,251,000
+1128.6%
70,768
+1628.2%
0.02%
+1150.0%
Q2 2019$346,000
-94.5%
4,095
-94.4%
0.00%
-93.3%
Q3 2018$6,253,000
-32.1%
73,166
-7.9%
0.03%
-28.6%
Q2 2018$9,208,000
+12.0%
79,447
-21.8%
0.04%
+10.5%
Q1 2018$8,221,000
+40.7%
101,604
+2.1%
0.04%
+52.0%
Q4 2017$5,841,000
+288.1%
99,548
+209.5%
0.02%
+257.1%
Q3 2017$1,505,000
-77.6%
32,167
-84.0%
0.01%
-75.0%
Q4 2016$6,714,000
-37.9%
200,422
-50.7%
0.03%
-39.1%
Q3 2016$10,811,000
+736.1%
406,265
+592.8%
0.05%
+666.7%
Q2 2016$1,293,000
-49.8%
58,643
-33.1%
0.01%
-45.5%
Q1 2016$2,576,000
+260.3%
87,716
+343.5%
0.01%
+266.7%
Q3 2015$715,000
-81.5%
19,778
-77.0%
0.00%
-82.4%
Q2 2015$3,872,00086,0600.02%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 519,035$60,156,00015.36%
Matarin Capital Management, LLC 201,703$23,377,378,0001.69%
ARMISTICE CAPITAL, LLC 124,000$14,372,0000.94%
Sapphire Star Partners LP 7,803$904,0000.93%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 98,631$11,431,0000.83%
FARALLON CAPITAL MANAGEMENT LLC 1,075,000$124,593,0000.77%
Granahan Investment Management 100,670$11,668,0000.70%
Virtus ETF Advisers LLC 6,577$762,0000.67%
AlphaMark Advisors, LLC 11,115$1,288,0000.52%
Ativo Capital Management LLC 15,029$1,742,0000.48%
View complete list of ENANTA PHARMACEUTICALS INC shareholders